Related Experiment Video
Updated: Jun 19, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
RESULTS OF PROPHYLACTIC VACCINATION AGAINST PNEUMONIA AT CAMP WHEELER
The Journal of Experimental Medicine
|October 30, 2009
Summary
Pneumococcus vaccination significantly reduced pneumonia incidence and mortality in military personnel. While influenza impacted efficacy, the vaccine demonstrated encouraging results for broader application in military and civilian life.
Area of Science:
- Medical Microbiology
- Preventive Medicine
- Epidemiology
Background:
- Pneumonia posed a significant health risk in military settings.
- Pneumococcus bacteria are a leading cause of pneumonia.
- Vaccination strategies were being explored to mitigate pneumonia outbreaks.
Purpose of the Study:
- To evaluate the efficacy of pneumococcus lipovaccine in preventing pneumonia among military recruits.
- To assess the safety and reactogenicity of the pneumococcus vaccine.
- To compare pneumonia incidence and mortality rates between vaccinated and unvaccinated groups.
Main Methods:
- 13,460 men were vaccinated with a pneumococcus lipovaccine (Types I, II, III).
- Vaccine dosage was 1 cc, containing approximately 10 billion of each pneumococcus type.
- Incidence and mortality data were collected and compared between vaccinated and unvaccinated groups over 2-3 months.
Main Results:
- Vaccination resulted in milder local and general reactions, with only 0.7% requiring hospitalization.
- Pneumonia incidence rates were lower in vaccinated troops compared to unvaccinated.
- The pneumonia incidence rate was 2x higher in unvaccinated recruits and 7x higher in unvaccinated seasoned men.
- The death rate for primary pneumonia was significantly lower in vaccinated (11.9%) versus unvaccinated (31.8%) individuals.
- Influenza significantly reduced resistance to pneumonia, even in vaccinated individuals.
Conclusions:
- Pneumococcus vaccination demonstrated encouraging efficacy in reducing pneumonia incidence and mortality.
- The vaccine was generally safe with mild reactions.
- Influenza epidemics can obscure vaccine efficacy but do not negate its protective benefits.
- Results support the further application of pneumococcus vaccination in both military and civilian populations.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:51Vaccinations
Overview
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: